Financial toxicity in cancer care

Jeremy M. O'connor, Sheetal M. Kircher, Jonas A. De Souza*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


The cost of cancer care is increasing, with important implicatons for the delivery of high-quality, patent-centered care. In the clinical setng, patents and physicians express a desire to discuss out-of-pocket costs. Nevertheless, both groups feel inadequately prepared to partcipate in these discussions, and perhaps not surprisingly, the integraton of these discussions into clinical practce seems to be the excepton rather than the rule. The resultng neglect of financial issues has the potental to cause unnecessary suffering for oncology patents. In this paper, we review the most relevant literature on financial toxicity in cancer care. In additon, we discuss potental predictors of financial toxicity, and the recent development of instruments to help clinicians and researchers quantfy financial burden.

Original languageEnglish (US)
Pages (from-to)101-106
Number of pages6
JournalJournal of Community and Supportive Oncology
Issue number3
StatePublished - Mar 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Financial toxicity in cancer care'. Together they form a unique fingerprint.

Cite this